ONCOSEC MEDICAL Inc Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ONCOSEC MEDICAL Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2022.
  • ONCOSEC MEDICAL Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending October 31, 2022 was -$343K, a 6.61% increase year-over-year.
  • ONCOSEC MEDICAL Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$1.16M, a 102% decline from 2021.
  • ONCOSEC MEDICAL Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $68.2M, a 140% increase from 2020.
  • ONCOSEC MEDICAL Inc annual Net Cash Provided by (Used in) Financing Activities for 2020 was $28.4M, a 4.42% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$1.16M -$69.4M -102% Aug 1, 2021 Jul 31, 2022 10-K 2022-10-31
2021 $68.2M +$39.8M +140% Aug 1, 2020 Jul 31, 2021 10-K 2022-10-31
2020 $28.4M +$1.2M +4.42% Aug 1, 2019 Jul 31, 2020 10-K 2021-10-29
2019 $27.2M -$11.7M -30.1% Aug 1, 2018 Jul 31, 2019 10-K 2020-10-28
2018 $38.9M +$38.8M +60649% Aug 1, 2017 Jul 31, 2018 10-K/A 2019-11-27
2017 $64K Aug 1, 2016 Jul 31, 2017 10-K 2018-10-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.